Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

POPULATION PHARMACOMETRICS FOR ASSESSING RISK OF BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAW (BRONJ)

NCT02069340 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT02069340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02069340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
POPULATION PHARMACOMETRICS FOR ASSESSING RISK OF BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAW (BRONJ)
Lead sponsor
University of Southern California
Phase
Not applicable
Overall status
Withdrawn
Start date
June 30, 2016
Completion date
June 30, 2021
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

malignant neoplasm, musculoskeletal complications